212 related articles for article (PubMed ID: 10340889)
1. Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction.
Polkowski W; van Sandick JW; Offerhaus GJ; ten Kate FJ; Mulder J; Obertop H; van Lanschot JJ
Ann Surg Oncol; 1999; 6(3):290-7. PubMed ID: 10340889
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
3. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
6. The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma.
van der Kaaij RT; Snaebjornsson P; Voncken FE; van Dieren JM; Jansen EP; Sikorska K; Cats A; van Sandick JW
Eur J Cancer; 2017 May; 76():27-35. PubMed ID: 28262585
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
8. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of the two types of gastric adenocarcinoma in Iceland according to the Laurén histological classification 1990-2009].
Olafsdottir HS; Alexiusdottir KK; Lund SH; Jonasson JG; Jonsson T; Skuladottir H
Laeknabladid; 2016 Mar; 102(3):125-30. PubMed ID: 26985590
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
11. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
12. Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.
Tanner M; Hollmén M; Junttila TT; Kapanen AI; Tommola S; Soini Y; Helin H; Salo J; Joensuu H; Sihvo E; Elenius K; Isola J
Ann Oncol; 2005 Feb; 16(2):273-8. PubMed ID: 15668283
[TBL] [Abstract][Full Text] [Related]
13. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
Dis Esophagus; 2007; 20(1):36-41. PubMed ID: 17227308
[TBL] [Abstract][Full Text] [Related]
14. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
15. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
[TBL] [Abstract][Full Text] [Related]
16. Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review.
Aurello P; D'Angelo F; Nigri G; Bellagamba R; Cicchini C; Ruzzetti R; Ramacciato G
Am Surg; 2006 Feb; 72(2):118-23. PubMed ID: 16536239
[TBL] [Abstract][Full Text] [Related]
17. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.
Qiu MZ; Cai MY; Zhang DS; Wang ZQ; Wang DS; Li YH; Xu RH
J Transl Med; 2013 Mar; 11():58. PubMed ID: 23497313
[TBL] [Abstract][Full Text] [Related]
20. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]